CAPLIPOINT

NSE#314 by turnover

Caplin Point Laboratories Limited

₹2,835.10-32.30 (-1.13%)Close, 25 Sept 2026

Key statistics

Open: ₹2,867.00
Day range: 2,785.00 – 2,909.60
52-week range: 1,500.30 – 2,990.00
From 52w high: -5.2%
Volume: 1.81L
Turnover: ₹51.4Cr
Delivery: 20.5%
Rel volume: 0.54×
RSI (14): 60.8
ATR (14): 110.05
SMA 50: 2,619.48
SMA 200: 2,100.08

Performance

1 day: -1.13%
1 week: +3.15%
1 month: +12.67%
3 months: +10.84%
6 months: +81.70%
1 year: +22.12%

Delivery percentage

Latest: 20.5%
20-day avg: 32.9%
1-year avg: 46.1%
Percentile: 4th
Range: 5.8–84.2%

Over the last 20 sessions CAPLIPOINT settled 32.9% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 46.1%, so recent sessions are running 13.2 points lower than usual. The latest session ranks higher than 4% of the 1,725 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

Fundamentals

Market cap: ₹21,550 Cr
P/E (TTM): 31.78
EPS (TTM): ₹89.20
Shares outstanding: 7.60Cr
Listed: 23 Jun 2014

Classification

Macro sector: Healthcare
Sector: Healthcare
Industry: Pharmaceuticals & Biotechnology
Basic industry: Pharmaceuticals

NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.

Growthlatest filed quarter Q1 FY27

Revenue YoY: +19.63%
Profit YoY: +18.79%
Revenue QoQ: +1.70%
Profit QoQ: +3.59%
Interest cost YoY: —

Compound growth

Not enough filed history for a compound growth rate yet.

Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.

About

ISIN: INE475E01026
Series: EQ
History from: 23 Jun 2014
Sessions: 3,031

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.